Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry G Bone

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|March 25, 2009
Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 studyGeorgiana K Ellis, Henry G Bone, Rowan Chlebowski, et al.
Bone|January 31, 2004
Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2Dennis B Henriksen, Peter Alexandersen, Inger Byrjalsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled studyHenry G Bone, Robert Lindsay, Michael R McClung, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2015
Response to letterFrederick R Singer, Henry G Bone, David J Hoskings, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2015
Response to letter by Ralston et alFrederick R Singer, Henry G Bone, David J Hosking, et al.
Pharmacotherapy|May 30, 2009
Vitamin D and cardiovascular diseaseCarrie W Nemerovski, Michael P Dorsch, Robert U Simpson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2008
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancerGeorgiana K Ellis, Henry G Bone, Rowan Chlebowski, et al.
Current Medical Research and Opinion|September 24, 2020
Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosisPaul D Miller, John P Bilezikian, Lorraine A Fitzpatrick, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral densityLorraine A Fitzpatrick, Christine E Dabrowski, Gregory Cicconetti, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2008
Effects of denosumab on bone mineral density and bone turnover in postmenopausal womenHenry G Bone, Michael A Bolognese, Chui Kin Yuen, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|March 25, 2009
Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 studyGeorgiana K Ellis, Henry G Bone, Rowan Chlebowski, et al.
Bone|January 31, 2004
Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2Dennis B Henriksen, Peter Alexandersen, Inger Byrjalsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled studyHenry G Bone, Robert Lindsay, Michael R McClung, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2015
Response to letterFrederick R Singer, Henry G Bone, David J Hoskings, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2015
Response to letter by Ralston et alFrederick R Singer, Henry G Bone, David J Hosking, et al.
Pharmacotherapy|May 30, 2009
Vitamin D and cardiovascular diseaseCarrie W Nemerovski, Michael P Dorsch, Robert U Simpson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2008
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancerGeorgiana K Ellis, Henry G Bone, Rowan Chlebowski, et al.
Current Medical Research and Opinion|September 24, 2020
Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosisPaul D Miller, John P Bilezikian, Lorraine A Fitzpatrick, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral densityLorraine A Fitzpatrick, Christine E Dabrowski, Gregory Cicconetti, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2008
Effects of denosumab on bone mineral density and bone turnover in postmenopausal womenHenry G Bone, Michael A Bolognese, Chui Kin Yuen, et al.
Pageof 6